KORU Medical Systems (KRMD) and Its Competitors Financial Analysis

KORU Medical Systems (NASDAQ:KRMD) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare KORU Medical Systems to related businesses based on the strength of its institutional ownership, valuation, dividends, profitability, earnings, risk and analyst recommendations.

Insider and Institutional Ownership

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for KORU Medical Systems and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1	0	4	1	2.83
KORU Medical Systems Competitors	4251	10479	18202	824	2.46

KORU Medical Systems currently has a consensus target price of $7.00, suggesting a potential upside of 134.11%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.57%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, research analysts clearly believe KORU Medical Systems is more favorable than its rivals.

Risk and Volatility

KORU Medical Systems has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, KORU Medical Systems’ rivals have a beta of 2.52, suggesting that their average share price is 152% more volatile than the S&P 500.

Earnings & Valuation

This table compares KORU Medical Systems and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
KORU Medical Systems	$41.13 million	-$2.64 million	-74.75
KORU Medical Systems Competitors	$1.89 billion	$137.23 million	10.69

KORU Medical Systems’ rivals have higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares KORU Medical Systems and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
KORU Medical Systems Competitors	-278.23%	-150.07%	-21.87%

Summary

KORU Medical Systems beats its rivals on 9 of the 13 factors compared.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.